SCHEMBL555796

SCHEMBL555796

CC(C)[Si](OCC1CN(C(=O)OC(C)(C)C)CCC1O)(C(C)C)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
TRPV3 Q8NET8 2/20 0.38
GPR119 Q8TDV5 5/20 0.38
HTT P42858 2/20 0.37
NPC1 O15118 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
RECQL P46063 1/20 0.37
EPHX1 P07099 1/20 0.37
NR1H2 P55055 1/20 0.36
ATM Q13315 1/20 0.36
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
USP30 Q70CQ3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15076451 0.84 RECQL (0.40) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL34468045 0.84 RECQL (0.40) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL2902193 0.82 PDE4B (0.44) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL7516819 0.81 HPGD (0.46) ALDH1A1MAPTHPGDGPR119HTT
SCHEMBL23600144 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL23527243 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL23527255 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL23527253 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL23527242 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD
SCHEMBL19958826 0.80 HPGD (0.47) ALDH1A1MAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120035214-A1 RENIN INHIBITORS MERCK CANADA INC. (CA) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035214-A1 RENIN INHIBITORS REN, ACE, AGTR1 ALDH1A1 900/4885MAPT 4208/4885MEN1 4385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.